doi: 10.1016/j.diabres.2013.11.014
Scientists are now investigating whether GLP-1 drugs could help treat substance use disorders, which also involve dopamine-driven reward pathways
Their regulatory approval for obesity (liraglutide in 2014 and semaglutide in 20212022) may also contribute to the predominance of older individuals among treated people [3, 18, 19]
In Stock PTR000418 Offer : Use Coupon code GET100 OFF while checkout and get additional 100 Rs discount, Applicable for Today Only
This study shows that as new medications are approved we need to be careful as long term side-effects may be seen that we were not aware of. Diabetes is very common in our practices and many of our patients are put on the GPL-1s, Geffen continued
Springer, Singapore, pp 329 Chen H et al (2009) Study on the toxic effects of diphenol compounds on soil microbial activity by a combination of methods